주식회사 지엔티파마

{
  "address": "경기도 용인시",
  "ceo_name": "곽병주",
  "certificate": [
    {
      "cert_number": "1999163512-0665",
      "changes": "",
      "disclosure_date": "1999-05-10",
      "first_cert_date": "1999-05-10",
      "no": "1",
      "type": "벤처투자기업(창투사등이 자본금 10%이상 투자)",
      "valid_period": "1999-05-10 ~ 2000-12-31"
    },
    {
      "cert_number": "20001622122616",
      "changes": "",
      "disclosure_date": "2000-12-28",
      "first_cert_date": "1999-05-10",
      "no": "2",
      "type": "기타",
      "valid_period": "2000-12-28 ~ 2002-12-27"
    },
    {
      "cert_number": "031622011300077",
      "changes": "",
      "disclosure_date": "2002-12-28",
      "first_cert_date": "1999-05-10",
      "no": "3",
      "type": "벤처투자기업(창투사등이 자본금 10%이상 투자)",
      "valid_period": "2002-12-28 ~ 2003-12-27"
    },
    {
      "cert_number": "051622011500288",
      "changes": "",
      "disclosure_date": "2005-03-11",
      "first_cert_date": "1999-05-10",
      "no": "4",
      "type": "벤처투자기업(창투사등이 자본금 10%이상 투자)",
      "valid_period": "2005-03-11 ~ 2006-03-10"
    },
    {
      "cert_number": "061622011600467",
      "changes": "",
      "disclosure_date": "2006-03-11",
      "first_cert_date": "1999-05-10",
      "no": "5",
      "type": "벤처투자기업(창투사등이 자본금 10%이상 투자)",
      "valid_period": "2006-03-11 ~ 2007-03-10"
    },
    {
      "cert_number": "20070400084",
      "changes": "",
      "disclosure_date": "2007-04-06",
      "first_cert_date": "1999-05-10",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2007-03-11 ~ 2009-03-10"
    },
    {
      "cert_number": "20090400230",
      "changes": "",
      "disclosure_date": "2009-03-30",
      "first_cert_date": "1999-05-10",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2009-03-11 ~ 2011-03-10"
    },
    {
      "cert_number": "20110400119",
      "changes": "",
      "disclosure_date": "2011-04-05",
      "first_cert_date": "1999-05-10",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2011-03-11 ~ 2013-03-10"
    },
    {
      "cert_number": "20160402068",
      "changes": "",
      "disclosure_date": "2016-12-08",
      "first_cert_date": "1999-05-10",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2016-12-08 ~ 2018-12-07"
    },
    {
      "cert_number": "20200300734",
      "changes": "",
      "disclosure_date": "2020-07-02",
      "first_cert_date": "1999-05-10",
      "no": "10",
      "type": "벤처투자유형",
      "valid_period": "2020-07-02 ~ 2022-07-01"
    },
    {
      "cert_number": "20220622020059",
      "changes": "",
      "disclosure_date": "2022-06-22",
      "first_cert_date": "1999-05-10",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2022-07-02 ~ 2025-07-01"
    },
    {
      "cert_number": "20250827020014",
      "changes": "",
      "disclosure_date": "2025-08-27",
      "first_cert_date": "1999-05-10",
      "no": "12",
      "type": "연구개발유형",
      "valid_period": "2025-07-02 ~ 2028-07-01"
    }
  ],
  "company_name": "주식회사 지엔티파마",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 7930244000,
      "cost_of_sales": 215941000,
      "current_assets": 13568226000,
      "current_liabilities": 3628914000,
      "gross_profit": 935768000,
      "net_income": -8202783000,
      "net_income_bs": -8202782000,
      "non_current_assets": 12945629000,
      "non_current_liabilities": 1275852000,
      "non_operating_expenses": 374652000,
      "non_operating_income": 515987000,
      "operating_profit": -8344118000,
      "revenue": 1151709000,
      "sga_expenses": 9279886000,
      "total_assets": 26513855000,
      "total_equity": 21609089000,
      "total_liabilities": 4904766000
    },
    "2023": {
      "capital_stock": 7930244000,
      "cost_of_sales": 249486000,
      "current_assets": 2774982000,
      "current_liabilities": 4603588000,
      "gross_profit": 449292000,
      "net_income": -19589900000,
      "net_income_bs": -19589900000,
      "non_current_assets": 5685004000,
      "non_current_liabilities": 1185951000,
      "non_operating_expenses": 9233640000,
      "non_operating_income": 307636000,
      "operating_profit": -10663896000,
      "revenue": 698778000,
      "sga_expenses": 11113188000,
      "total_assets": 8459985000,
      "total_equity": 2670446000,
      "total_liabilities": 5789539000
    },
    "2024": {
      "capital_stock": 7941244000,
      "cost_of_sales": 138689000,
      "current_assets": 1113257000,
      "current_liabilities": 4978163000,
      "gross_profit": 242213000,
      "net_income": -5313376000,
      "net_income_bs": -5313376000,
      "non_current_assets": 7488550000,
      "non_current_liabilities": 1195346000,
      "non_operating_expenses": 474751000,
      "non_operating_income": 2323594000,
      "operating_profit": -7162219000,
      "revenue": 380902000,
      "sga_expenses": 7404432000,
      "total_assets": 8601807000,
      "total_equity": 2428299000,
      "total_liabilities": 6173508000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "792,675,000",
      "changes": "792,675,000",
      "date": "2017-11-13"
    }
  ],
  "main_products": "뇌졸중 치료제, 반려견 치매치료제",
  "phone": "031-8005-****",
  "years": [
    2024,
    2023,
    2022
  ]
}